According to the research report, the global U.S. pharmacy benefit management market size is expected to touch USD 1,219.54 Billion by 2032, from USD 513.26 Billion in 2022, growing with a significant CAGR of 9.04% from 2023 to 2032.
Key Takeaways:
- By Business Model, the standalone PBM segment dominated the market with the largest market share of 60% in 2022.
- By Business Model, the healthcare insurance provider segment is expected to generate significant revenue throughout the forecast period.
- By Services, the specialty pharmacies segment dominated the market in 2022.
- By Services, the retail services segment is expected to witness significant growth during the predicted timeframe.
- By End-user, the commercial segment projected the highest market growth in 2022.
- By End-user, the federal segment is expected to dominate the market during the anticipated time period.
The U.S. pharmacy benefit management report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global U.S. pharmacy benefit management in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global U.S. pharmacy benefit management market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global U.S. pharmacy benefit management during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/3225
This study covers a detailed segmentation of the global U.S. pharmacy benefit management market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global U.S. pharmacy benefit management market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- CVS Health
- Cigna
- Optum, Inc.
- MedImpact
- Anthem
- Change Healthcare
- Prime Therapeutics LLC
- HUB International Limited.
- Elixir Rx Solutions LLC
Market Segmentation
By Business Model
- Standalone PBM
- Health Insurance Providers
By Service
- Specialty Pharmacy
- Retail Pharmacy
By End-user
- Commercial
- Federal
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global U.S. pharmacy benefit management report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global U.S. pharmacy benefit management market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Pharmacy Benefit Management Market
5.1. COVID-19 Landscape: U.S. Pharmacy Benefit Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Pharmacy Benefit Management Market, By Business Model
8.1. U.S. Pharmacy Benefit Management Market, by Business Model, 2023-2032
8.1.1 Standalone PBM
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Health Insurance Providers
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. U.S. Pharmacy Benefit Management Market, By Service
9.1. U.S. Pharmacy Benefit Management Market, by Service, 2023-2032
9.1.1. Specialty Pharmacy
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Retail Pharmacy
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. U.S. Pharmacy Benefit Management Market, By End-user
10.1. U.S. Pharmacy Benefit Management Market, by End-user, 2023-2032
10.1.1. Commercial
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Federal
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. U.S. Pharmacy Benefit Management Market, Estimate and Trends Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Business Model (2020-2032)
11.1.2. Market Revenue and Forecast, by Service (2020-2032)
11.1.3. Market Revenue and Forecast, by End-user (2020-2032)
Chapter 12. Company Profiles
12.1. CVS Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cigna
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Optum, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. MedImpact
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Anthem
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Change Healthcare
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Prime Therapeutics LLC
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. HUB International Limited.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Elixir Rx Solutions LLC
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Abbott
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments